Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Frequently asked questions
What sector does Adhera Therapeutics Inc (ATRX) operate in?
Adhera Therapeutics Inc belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Adhera Therapeutics Inc (ATRX) current stock price?
As of the latest data, Adhera Therapeutics Inc stock price is $0.00, with a previous close of $0.00.
What is Adhera Therapeutics Inc (ATRX) current market capitalization?
Adhera Therapeutics Inc market cap is approximately 722.09.
What is Adhera Therapeutics Inc (ATRX) Earnings Per Share (EPS)?
The trailing EPS is -$1.18.
Does Adhera Therapeutics Inc (ATRX) pay dividends?
No. Adhera Therapeutics Inc does not pay a dividend.
What is Adhera Therapeutics Inc (ATRX) beta (volatility) score?
Adhera Therapeutics Inc has a beta of 718.016, indicating very high volatility compared to the market.